Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-24 @ 3:43 PM
NCT ID:
NCT03591692
Eligibility Criteria:
Inclusion Criteria:
1. patients aged 45-70 years, without gender limitation, are willing to sign informed consent;
2. patients diagnosed with posterior longitudinal ligament ossification of the cervical spine;
3. patients with limbs numbness, walking instability, banding and other spinal cord, nerve root compression symptoms, may be associated with urinary dysfunction, conservative treatment is invalid or gradually increased;
Exclusion Criteria:
1. Cervical ligamentous ossification, cervical trauma, cervical cancer, cervical tuberculosis and other inflammatory diseases;
2. accompanied by thoracolumbar spine and other spine parts of the disease affect the clinical symptoms of patients;
3. associated with amyotrophic lateral sclerosis and other motor neuron diseases and other neurological diseases;
4. poor health condition, unable to tolerate surgery;
5. patients (or their guardians) can not give full informed consent for adult dysfunction;
6. patients who have participated in other clinical trials in the past 1 month
7. patients with active hepatitis B (including HBeAg) or serological markers (HBsAg or / and HBeAg or / and HBcAb), hepatitis C, tuberculosis, cytomegalovirus infection, severe fungal infection or HIV infection;
8. patients with active peptic ulcers within 3 months before randomization;
9. patients with malignant neoplasms;
10. Vertebral length more than 3 intervertebral spaces.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
70 Years
Study:
NCT03591692
Study Brief:
Protocol Section:
NCT03591692